Still feeling hungry on Mounjaro 15mg — is that normal?

Why are you still hungry on Mounjaro 15mg when the dose can go no higher?

Tirzepatide works by activating both GIP and GLP-1 receptors, slowing gastric emptying and signalling fullness to the brain. At 15mg those pathways are being stimulated as strongly as the licensed dose allows. Yet fullness signals compete with other biological inputs, stress hormones, sleep quality, diet composition, and the speed at which your stomach has adapted to the slower emptying. If those countervailing signals are strong enough, real hunger can still break through.

There is also a distinction worth making between true hunger and appetite or cravings. True hunger (a physical, grumbling emptiness several hours after a meal) suggests the medicine may not be fully suppressing your appetite. Cravings for specific foods, eating out of boredom, or feeling hungry shortly after a satisfying meal are more likely conditioned habits the medicine alone cannot overwrite. Separating the two is the first productive step.

A quick habit worth building: before reaching for food, take sixty seconds to run through four checks, time since your last meal, how much water you have had, whether you are tired, and whether you are stressed. Hunger that resolves with a glass of water or a short walk is usually not true gastric hunger. Tracking this for a week gives your prescriber concrete information rather than a general complaint.

The tirzepatide overview on our Mounjaro page covers how the medicine's dual mechanism works in more detail if you want the fuller picture.

What factors could be blunting the appetite effect at this dose?

Several factors are well recognised as reducing the practical effect of tirzepatide on appetite, even at 15mg. Protein intake is one of the most important. High-protein meals produce stronger and longer-lasting fullness signals than carbohydrate-heavy ones, and many people on GLP-1 medicines under-eat protein because their overall intake drops. Paradoxically, eating too little can also cause reactive hunger later in the day as blood sugar dips.

Sleep is another underestimated factor. Poor sleep raises ghrelin, the hormone that drives hunger, and can partly override tirzepatide's satiety signalling. Even one or two broken nights a week can make a measurable difference to how hungry you feel by mid-afternoon.

The timing of your injection matters too. Tirzepatide peaks in your system around 24–72 hours after injection, and some people notice hunger returning in the day or two before their next weekly dose is due. This is called end-of-dose effect, and while it does not mean the dose is wrong, it is useful information to share with your prescriber. You can find further background on dosing patterns on the typical Mounjaro dosage page.

Other medicines (particularly those affecting gastric motility or blood sugar) can also interact with how tirzepatide behaves. This is always worth raising at your next clinical review rather than adjusting anything independently. The nume FAQs page addresses some commonly asked questions about managing treatment day to day.

Is persistent hunger at 15mg a sign treatment is not working?

Not necessarily. Weight loss on tirzepatide does not require complete elimination of hunger. SURMOUNT-1, the pivotal clinical trial published in the New England Journal of Medicine, found average body-weight reductions of around 20–21% at 15mg across thousands of participants, many of whom presumably still experienced some hunger at points during the 72 weeks.

What matters more than appetite being fully silenced is whether you are still losing weight at a clinically meaningful rate, whether your eating behaviour has changed, and whether your quality of life has improved. If the answer to all three is yes, some residual hunger is not a clinical problem. If weight loss has stalled and hunger is increasing, that is a different conversation, one to have with your prescriber, who can assess whether something else is driving the plateau.

People who are earlier in their titration journey and still finding appetite control incomplete may find it useful to read about hunger at the 12.5mg dose or, if they are newer to the medicine, those just starting out can read about what hunger at the 2.5mg starting dose typically looks like and those a little further along can explore why hunger can persist at the 10mg stage for context on how the pattern typically evolves across doses. It is also worth knowing that hunger at the 5mg dose is a recognised pattern too, and understanding it can help put the broader titration picture into perspective.

When should you actually contact your prescriber about this?

Hunger that comes and goes is background noise. Hunger that is increasing at 15mg after several weeks of stability, or that is accompanied by a weight plateau or weight regain, is a clinical signal. So is any new or returning hunger that coincides with another change, a new medicine, a significant lifestyle disruption, or a health event.

The NHS patient information for tirzepatide makes clear that ongoing clinical support is part of how this medicine is meant to be used, not an optional extra. At nume, every repeat order goes through a fresh clinical review by a GPhC-registered prescriber, specifically to catch situations like this before they become a longer-term problem. If you want to discuss what you are experiencing before your next repeat, our contact page has priority aftercare options seven days a week.

It is also worth understanding that 15mg is where the licensed dose ladder ends. If appetite control remains inadequate despite optimising lifestyle factors and ruling out other causes, your prescriber may discuss whether tirzepatide at any dose is the right long-term fit, or whether the treatment plan needs adjusting in another way. That is a clinical conversation, not a failure. See what our clinical team looks for when reviewing cases like this, and if you want to explore your options more broadly, speak to our prescribers through a free consultation.

For further NHS-level information on tirzepatide, the NHS tirzepatide medicines page covers what to expect from treatment and when to seek help.